115K

115K is the corporate venture arm of La Banque Postale, the French postal-banking group, operating from Paris with a EUR 150M mandate. Stated focus areas are fintech, insurtech, and cyber, with no disclosed healthcare sub-vertical exposure. For physician AI and digital health founders, this is not a healthcare investor and should not be approached as one.

The relevance for healthcare-tangent founders is narrow but worth flagging where insurtech overlaps with health insurance, employer benefits, or population-health risk-stratification products that interact with French insurance carriers and corporate benefits buyers. In those cases, 115K could in principle be a strategic CVC partner via the La Banque Postale customer base, though founders should confirm current activity in health-adjacent insurtech rather than assume it from the stated focus areas. Portfolio companies are not disclosed in the input record.

Disclosed check size is $1M to $5M, with stages from seed through Series B and French geographic scope. As a CVC, the fund’s underwriting will weigh strategic alignment with La Banque Postale’s banking, insurance, and cyber priorities alongside financial return. Founders without a credible commercial relationship pathway into the parent should not invest pitch effort here.

Named team members are not provided in the input record. The firm’s website is the primary reference for partner identification.

Approach 115K only if you are a French insurtech founder whose product touches health insurance, employer benefits, or risk products that intersect with the La Banque Postale insurance arm, and you want both capital and a strategic commercial relationship with the parent. Physician AI tools, EHR software, clinical workflow automation, and payer-direct US healthcare plays are out of scope. The right entry, if a fit exists, is via a La Banque Postale insurance executive, a French insurtech advisor familiar with the CVC, or a portfolio founder. When pitching, lead with the strategic case for the parent and follow with the financial story, because CVC underwriting weighs both. Founders without a French nexus, without insurance-product overlap, or without the willingness to engage on a corporate-strategic basis are better served by healthcare-dedicated venture funds elsewhere in this directory.